Stockholders' Equity

9 Months Ended

Sep. 30, 2022

Stockholders' Equity

Stockholders' Equity

7. Stockholders’ Equity

The changes in condensed consolidated stockholders’ equity for the three and nine months ended September 30, 2022 and 2021, are as follows:

	Common Stock Shares		Common Stock Amount		Additional Paid-In Capital			Accumulated  Deficit			Treasury Stock			Total
Balance at December 31, 2021		18,298,999	$	10,979	$	35,862		$	(8,821	)	$	(5,402	)	$	32,618
Common stock issued under restricted stock units		16,000		10		(10	)		—			—			—
Share-based compensation expense-stock options		—		—		85			—			—			85
Share-based compensation expense-restricted stock units		—		—		70			—			—			70
Net loss		—		—		—			(3,936	)		—			(3,936	)
Balance at March 31, 2022		18,314,999		10,989		36,007			(12,757	)		(5,402	)		28,837
Common stock issued under restricted stock units		53,864		32		(32	)		—			—			—
Share-based compensation expense-stock options		—		—		51			—			—			51
Share-based compensation expense-restricted stock units		—		—		171			—			—			171
Common stock dividends ($0.03 per share)		—		—		—			(1,014	)		—			(1,015	)
Net loss		—		—		—			(4,334	)		—			(4,334	)
Balance at June 30, 2022		18,368,863		11,021		36,197			(18,105	)		(5,402	)		23,711
Common stock issued under restricted stock units		65,834		40		(40	)		—			—			—
Share-based compensation expense-stock options		—		—		69			—			—			69
Share-based compensation expense-restricted stock units		—		—		126			—			—			126
Common stock dividends ($0.03 per share)		—		—		—			(511	)		—			(511	)
Net loss		—		—		—			(2,402	)		—			(2,402	)
Balance at September 30, 2022		18,434,697	$	11,061	$	36,352		$	(21,018	)	$	(5,402	)	$	20,993

	Common Stock Shares		Common Stock Amount		Additional Paid-In Capital			Accumulated  Deficit			Treasury Stock			Total
Balance at December 31, 2020*		13,962,366	$	8,377	$	26,346		$	(5,693	)	$	(5,402	)	$	23,628
Common stock issued under restricted stock units		24,505		15		(15	)		—			—			—
Share-based compensation expense-stock options		—		—		32			—			—			32
Share-based compensation expense-restricted stock units		—		—		103			—			—			103
Common stock dividends ($0.02 per share)		—		—		—			(251	)		—			(251	)
Net loss*		—		—		—			(670	)		—			(670	)
Balance at March 31, 2021*		13,986,871		8,392		26,466			(6,614	)		(5,402	)		22,842
Common stock issued, net of issuance costs		4,249,250		2,549		9,010			—			—			11,559
Share-based compensation expense-stock options		—		—		33			—			—			33
Share-based compensation expense-restricted stock units		—		—		25			—			—			25
Net income*		—		—		—			1,838			—			1,838
Balance at June 30, 2021*		18,236,121		10,941		35,534			(4,776	)		(5,402	)		36,297
Common stock issued under restricted stock units		28,615		17		(17	)		—			—			—
Share-based compensation expense-stock options		—		—		150			—			—			150
Share-based compensation expense-restricted stock units		—		—		34			—			—			34
Common stock dividends ($0.02 per share)		—		—		—			(671	)		—			(671	)
Net loss		—		—		—			(2,566	)		—			(2,566	)
Balance at September 30, 2021		18,264,736	$	10,958	$	35,701		$	(8,013	)	$	(5,402	)	$	33,244

*The balances as of December 31, 2020, March 31, 2021, and June 30, 2021 and the amounts for the three months ended March 31, 2021 and June 30, 2021, have been adjusted to reflect the change in inventory accounting method, as described in Notes 1 and 4 of the Condensed Consolidated Financial Statements.